Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Françoise Van Bambeke

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Procedures

Microbial Sensitivity Tests

Living Beings

Physiology

Bacterial Drug Resistance

Concepts & Ideas

Drug Dose-Response Relationship

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
74
Tulkens, Paul
45
Mingeot-Leclercq, Marie-Paule
14
Lemaire, Sandrine
8
Brasseur, Robert
8
Schanck, André
8
Seral, Cristina
7
Michot, Jean-Michel
7
Carryn, Stéphane
6
Glupczynski, Youri
5
Chanteux, Hugues
5
Barcia-Macay, Maritza
4
Courvalin, Patrice
4
Van Der Smissen, Patrick
3
Struelens, Marc
3
NGUYEN, Hoang Anh

Sign-in to see all Coauthors

Publications

TOP 3
Olivier Aurélie C; Lemaire Sandrine; Van Bambeke Françoise; Tulkens Paul M; Oldfield Eric
Role of rsbU and staphyloxanthin in phagocytosis and intracellular growth of Staphylococcus aureus in human macrophages and endothelial cells.
Lemaire Sandrine; Van Bambeke Françoise; Appelbaum Peter C; Tulkens Paul M
Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines.
Brinch Karoline Sidelmann; Sandberg Anne; Baudoux Pierre; Van Bambeke Françoise; Tulkens Paul M; Frimodt-Møller Niels; Høiby Niels; Kristensen Hans-Henrik
Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in a mouse peritonitis model.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Françoise Van Bambeke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Olivier Aurélie C; Lemaire Sandrine; Van Bambeke Françoise; Tulkens Paul M; Oldfield Eric
Role of rsbU and staphyloxanthin in phagocytosis and intracellular growth of Staphylococcus aureus in human macrophages and endothelial cells.
The Journal of infectious diseases 2009;200(9):1367-70.
2009: Lemaire Sandrine; Van Bambeke Françoise; Appelbaum Peter C; Tulkens Paul M
Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines.
The Journal of antimicrobial chemotherapy 2009;64(5):1035-43.
2009: Brinch Karoline Sidelmann; Sandberg Anne; Baudoux Pierre; Van Bambeke Françoise; Tulkens Paul M; Frimodt-Møller Niels; Høiby Niels; Kristensen Hans-Henrik
Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in a mouse peritonitis model.
Antimicrobial agents and chemotherapy 2009;53(11):4801-8.
2009: Lemaire Sandrine; Van Bambeke Françoise; Tulkens Paul M
Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.
Antimicrobial agents and chemotherapy 2009;53(9):3734-43.
2009: Domenech Oscar; Francius Grégory; Tulkens Paul M; Van Bambeke Françoise; Dufrêne Yves; Mingeot-Leclercq Marie-Paule
Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization.
Biochimica et biophysica acta 2009;1788(9):1832-40.
2009: Van Bambeke F; Tulkens P M
[Pharmacodynamics of antibiotics in CSF: principles and consequences (predictive factors of efficacy)]
Médecine et maladies infectieuses 2009;39(7-8):483-92.
2009: Marquez Béatrice; Caceres Nancy E; Mingeot-Leclercq Marie-Paule; Tulkens Paul M; Van Bambeke Françoise
Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells.
Antimicrobial agents and chemotherapy 2009;53(6):2410-6.
2009: Lemaire Sandrine; Glupczynski Youri; Duval Valérie; Joris Bernard; Tulkens Paul M; Van Bambeke Françoise
Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2009;53(6):2289-97.
2009: Nguyen Hoang Anh; Denis Olivier; Vergison Anne; Tulkens Paul M; Struelens Marc J; Van Bambeke Françoise
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations.
Antimicrobial agents and chemotherapy 2009;53(4):1443-9.
2009: Nguyen Hoang Anh; Denis Olivier; Vergison Anne; Theunis Anne; Tulkens Paul M; Struelens Marc J; Van Bambeke Françoise
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains.
Antimicrobial agents and chemotherapy 2009;53(4):1434-42.
2009: Van Bambeke Françoise; Tulkens Paul M
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(5):359-78.
2009: Becker Jean-Paul; Depret Grégoire; Van Bambeke Françoise; Tulkens Paul M; Prévost Martine
Molecular models of human P-glycoprotein in two different catalytic states.
BMC structural biology 2009;9():3.
2008: Bensikaddour Hayet; Snoussi Karim; Lins Laurence; Van Bambeke Françoise; Tulkens Paul M; Brasseur Robert; Goormaghtigh Erik; Mingeot-Leclercq Marie-Paule
Interactions of ciprofloxacin with DPPC and DPPG: fluorescence anisotropy, ATR-FTIR and 31P NMR spectroscopies and conformational analysis.
Biochimica et biophysica acta 2008;1778(11):2535-43.
2008: Lismond Ann; Tulkens Paul M; Mingeot-Leclercq Marie-Paule; Courvalin Patrice; Van Bambeke Françoise
Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.
Antimicrobial agents and chemotherapy 2008;52(9):3040-6.
2008: Van de Velde Sébastien; Nguyen Hoang Anh; Van Bambeke Françoise; Tulkens Paul M; Grellet Jean; Dubois Véronique; Quentin Claudine; Saux Marie-Claude
Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.
The Journal of antimicrobial chemotherapy 2008;62(3):518-21.
2008: Lemaire S; Kosowska-Shick K; Julian K; Tulkens P M; Van Bambeke F; Appelbaum P C
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2008;14(8):766-77.
2008: Lemaire Sandrine; Olivier Aurélie; Van Bambeke Françoise; Tulkens Paul M; Appelbaum Peter C; Glupczynski Youri
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
Antimicrobial agents and chemotherapy 2008;52(8):2797-805.
2008: Denamur Sophie; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.
Antimicrobial agents and chemotherapy 2008;52(6):2236-8.
2008: Barcia-Macay Maritza; Mouaden Fatima; Mingeot-Leclercq Marie-Paule; Tulkens Paul M; Van Bambeke Françoise
Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts).
The Journal of antimicrobial chemotherapy 2008;61(6):1288-94.
2008: Lemaire Sandrine; Fuda Cosimo; Van Bambeke Françoise; Tulkens Paul M; Mobashery Shahriar
Restoration of susceptibility of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics by acidic pH: role of penicillin-binding protein PBP 2a.
The Journal of biological chemistry 2008;283(19):12769-76.
2008: Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Struelens Marc J; Tulkens Paul M
The bacterial envelope as a target for novel anti-MRSA antibiotics.
Trends in pharmacological sciences 2008;29(3):124-34.
2008: Van Bambeke Françoise; Harms Joerg M; Van Laethem Yves; Tulkens Paul M
Ketolides: pharmacological profile and rational positioning in the treatment of respiratory tract infections.
Expert opinion on pharmacotherapy 2008;9(2):267-83.
2007: Avrain Laetitia; Garvey Mark; Mesaros Narcisa; Glupczynski Youri; Mingeot-Leclercq Marie-Paule; Piddock Laura J V; Tulkens Paul M; Vanhoof Raymond; Van Bambeke Françoise
Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.
The Journal of antimicrobial chemotherapy 2007;60(5):965-72.
2007: Lemaire Sandrine; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.
Antimicrobial agents and chemotherapy 2007;51(8):2748-57.
2007: Mathot Frédéric; Schanck A; Van Bambeke F; Ariën A; Noppe M; Brewster M; Préat V
Passive diffusion of polymeric surfactants across lipid bilayers.
Journal of controlled release : official journal of the Controlled Release Society 2007;120(1-2):79-87.
2007: Mesaros N; Nordmann P; Plésiat P; Roussel-Delvallez M; Van Eldere J; Glupczynski Y; Van Laethem Y; Jacobs F; Lebecque P; Malfroot A; Tulkens P M; Van Bambeke F
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2007;13(6):560-78.
2007: Lemaire Sandrine; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Glupczynski Youri; Tulkens Paul M
Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin.
Antimicrobial agents and chemotherapy 2007;51(5):1627-32.
2007: Mesaros Narcisa; Glupczynski Youri; Avrain Laëtitia; Caceres Nancy E; Tulkens Paul M; Van Bambeke Françoise
A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy 2007;59(3):378-86.
2007: Baudoux Pierre; Bles Nathalie; Lemaire Sandrine; Mingeot-Leclercq Marie-Paule; Tulkens Paul M; Van Bambeke Françoise
Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections.
The Journal of antimicrobial chemotherapy 2007;59(2):246-53.
2007: Van Bambeke Françoise; Reinert René R; Appelbaum Peter C; Tulkens Paul M; Peetermans Willy E
Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.
Drugs 2007;67(16):2355-82.
2006: Barcia-Macay Maritza; Lemaire Sandrine; Mingeot-Leclercq Marie-Paule; Tulkens Paul M; Van Bambeke Françoise
Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2006;58(6):1177-84.
2006: Van Bambeke Françoise
Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy.
Current opinion in investigational drugs (London, England : 2000) 2006;7(8):740-9.
2006: Van Bambeke Françoise; Pagès Jean-Marie; Lee Ving J
Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux.
Recent patents on anti-infective drug discovery 2006;1(2):157-75.
2006: Michot Jean-Michel; Heremans Marie F; Caceres Nancy E; Mingeot-Leclercq Marie-Paule; Tulkens Paul M; Van Bambeke Françoise
Cellular accumulation and activity of quinolones in ciprofloxacin-resistant J774 macrophages.
Antimicrobial agents and chemotherapy 2006;50(5):1689-95.
2006: Vandevuer Stéphane; Van Bambeke Françoise; Tulkens Paul M; Prévost Martine
Predicting the three-dimensional structure of human P-glycoprotein in absence of ATP by computational techniques embodying crosslinking data: insight into the mechanism of ligand migration and binding sites.
Proteins 2006;63(3):466-78.
2006: Servais Hélène; Jossin Yves; Van Bambeke Françoise; Tulkens Paul M; Mingeot-Leclercq Marie-Paule
Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation.
Antimicrobial agents and chemotherapy 2006;50(4):1213-21.
2006: Van Bambeke Françoise; Barcia-Macay Maritza; Lemaire Sandrine; Tulkens Paul M
Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives.
Current opinion in drug discovery & development 2006;9(2):218-30.
2006: Barcia-Macay Maritza; Seral Cristina; Mingeot-Leclercq Marie-Paule; Tulkens Paul M; Van Bambeke Françoise
Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.
Antimicrobial agents and chemotherapy 2006;50(3):841-51.
2006: Charvalos Ekatherina; Tzatzarakis Manolis N; Van Bambeke Françoise; Tulkens Paul M; Tsatsakis Aristidis M; Tzanakakis George N; Mingeot-Leclercq Marie-Paule
Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
The Journal of antimicrobial chemotherapy 2006;57(2):236-44.
2005: Servais Hélène; Van Der Smissen Patrick; Thirion Gaëtan; Van der Essen Gauthier; Van Bambeke Françoise; Tulkens Paul M; Mingeot-Leclercq Marie-Paule
Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria.
Toxicology and applied pharmacology 2005;206(3):321-33.
2005: Michot Jean-Michel; Seral Cristina; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.
Antimicrobial agents and chemotherapy 2005;49(6):2429-37.
2005: Lemaire Sandrine; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2005;55(6):897-904.
2005: Van Bambeke Françoise; Saffran Jennifer; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Mixed-lipid storage disorder induced in macrophages and fibroblasts by oritavancin (LY333328), a new glycopeptide antibiotic with exceptional cellular accumulation.
Antimicrobial agents and chemotherapy 2005;49(5):1695-700.
2005: Chanteux Hugues; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin.
Antimicrobial agents and chemotherapy 2005;49(4):1279-88.
2005: Van Bambeke F; Michot J-M; Van Eldere J; Tulkens P M
Quinolones in 2005: an update.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(4):256-80.
2005: Seral C; Barcia-Macay M; Mingeot-Leclercq M P; Tulkens P M; Van Bambeke F
Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
The Journal of antimicrobial chemotherapy 2005;55(4):511-7.
2005: Piret Jocelyne; Schanck André; Delfosse Sylvie; Van Bambeke Françoise; Kishore Bellamkonda K; Tulkens Paul M; Mingeot-Leclercq Marie-Paule
Modulation of the in vitro activity of lysosomal phospholipase A1 by membrane lipids.
Chemistry and physics of lipids 2005;133(1):1-15.
2004: Van Bambeke Françoise
Glycopeptides in clinical development: pharmacological profile and clinical perspectives.
Current opinion in pharmacology 2004;4(5):471-8.
2004: Van Bambeke Françoise; Carryn Stéphane; Seral Cristina; Chanteux Hugues; Tyteca Donatienne; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.
Antimicrobial agents and chemotherapy 2004;48(8):2853-60.
2004: Michot Jean-Michel; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter.
Antimicrobial agents and chemotherapy 2004;48(7):2673-82.
2004: Ben Abdelaziz Halim; Lemaire Sandrine; Carryn Stéphane; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Inhibition of TNF-alpha production in THP-1 macrophages by glatiramer acetate does not alter their susceptibility to infection by Listeria monocytogenes and does not impair the efficacy of ampicillin or moxifloxacin against intracellular bacteria.
The Journal of antimicrobial chemotherapy 2004;54(1):288-9.
2004: Carryn Stéphane; Van de Velde Sébastien; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Impairment of growth of Listeria monocytogenes in THP-1 macrophages by granulocyte macrophage colony-stimulating factor: release of tumor necrosis factor-alpha and nitric oxide.
The Journal of infectious diseases 2004;189(11):2101-9.
2004: Nassogne Marie-Cécile; Lizarraga Chantal; N'Kuli Francisca; Van Bambeke Françoise; Van Binst Roger; Wallemacq Pierre; Tulkens Paul M; Mingeot-Leclercq Marie-Paule; Levade Thierry; Courtoy Pierre J
Cocaine induces a mixed lysosomal lipidosis in cultured fibroblasts, by inactivation of acid sphingomyelinase and inhibition of phospholipase A1.
Toxicology and applied pharmacology 2004;194(2):101-10.
2004: Van Bambeke Françoise; Van Laethem Yves; Courvalin Patrice; Tulkens Paul M
Glycopeptide antibiotics: from conventional molecules to new derivatives.
Drugs 2004;64(9):913-36.
2003: Chanteux Hugues; Mingeot-Leclercq Marie-Paule; Sonveaux Etienne; Van Bambeke Françoise; Tulkens Paul M
Intracellular accumulation and activity of ampicillin used as free drug and as its phthalimidomethyl or pivaloyloxymethyl ester (pivampicillin) against Listeria monocytogenes in J774 macrophages.
The Journal of antimicrobial chemotherapy 2003;52(4):610-5.
2003: Carryn Stéphane; Chanteux Hugues; Seral Cristina; Mingeot-Leclercq Marie-Paule; Van Bambeke Françoise; Tulkens Paul M
Intracellular pharmacodynamics of antibiotics.
Infectious disease clinics of North America 2003;17(3):615-34.
2003: Seral Cristina; Van Bambeke Françoise; Tulkens Paul M
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.
Antimicrobial agents and chemotherapy 2003;47(7):2283-92.
2003: Seral Cristina; Carryn Stéphane; Tulkens Paul M; Van Bambeke Françoise
Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 2003;51(5):1167-73.
2003: Van Bambeke F; Glupczynski Y; Plésiat P; Pechère J C; Tulkens P M
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy.
The Journal of antimicrobial chemotherapy 2003;51(5):1055-65.
2003: Van Bambeke F; Michot J-M; Tulkens P M
Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics.
The Journal of antimicrobial chemotherapy 2003;51(5):1067-77.
2003: Carryn Stéphane; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model.
The Journal of antimicrobial chemotherapy 2003;51(4):1051-2.
2003: Seral Cristina; Michot Jean-Michel; Chanteux Hugues; Mingeot-Leclercq Marie-Paule; Tulkens Paul M; Van Bambeke Françoise
Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages.
Antimicrobial agents and chemotherapy 2003;47(3):1047-51.
2003: Mingeot-Leclercq Marie-Paule; Lins Laurence; Bensliman Mariam; Thomas Annick; Van Bambeke Françoise; Peuvot Jacques; Schanck André; Brasseur Robert
Piracetam inhibits the lipid-destabilising effect of the amyloid peptide Abeta C-terminal fragment.
Biochimica et biophysica acta 2003;1609(1):28-38.
2002: Mingeot-Leclercq Marie Paule; Lins Laurence; Bensliman Mariam; Van Bambeke Françoise; Van Der Smissen Patrick; Peuvot Jacques; Schanck André; Brasseur Robert
Membrane destabilization induced by beta-amyloid peptide 29-42: importance of the amino-terminus.
Chemistry and physics of lipids 2002;120(1-2):57-74.
2002: Tyteca Donatienne; Van Der Smissen Patrick; Mettlen Marcel; Van Bambeke Françoise; Tulkens Paul M; Mingeot-Leclercq Marie Paule; Courtoy Pierre J
Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages.
Experimental cell research 2002;281(1):86-100.
2002: Carryn Stéphane; Van Bambeke Françoise; Mingeot-Leclercq Marie-Paule; Tulkens Paul M
Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.
Antimicrobial agents and chemotherapy 2002;46(7):2095-103.
2001: Mingeot-Leclercq M P; Gallet X; Flore C; Van Bambeke F; Peuvot J; Brasseur R
Experimental and conformational analyses of interactions between butenafine and lipids.
Antimicrobial agents and chemotherapy 2001;45(12):3347-54.
2001: Tyteca D; Van Der Smissen P; Van Bambeke F; Leys K; Tulkens P M; Courtoy P J; Mingeot-Leclercq M P
Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts.
European journal of cell biology 2001;80(7):466-78.
2001: Gholizadeh Y; Prevost M; Van Bambeke F; Casadewall B; Tulkens P M; Courvalin P
Sequencing of the ddl gene and modeling of the mutated D-alanine:D-alanine ligase in glycopeptide-dependent strains of Enterococcus faecium.
Protein science : a publication of the Protein Society 2001;10(4):836-44.
2001: Van Bambeke F; Tulkens P M
Macrolides: pharmacokinetics and pharmacodynamics.
International journal of antimicrobial agents 2001;18 Suppl 1():S17-23.
2000: Van Bambeke F; Balzi E; Tulkens P M
Antibiotic efflux pumps.
Biochemical pharmacology 2000;60(4):457-70.
2000: Prévost M; Van Belle D; Tulkens P M; Courvalin P; Van Bambeke F
Modeling of Enterococcus faecalis D-alanine:D-alanine ligase: structure-based study of the active site in the wild-type enzyme and in glycopeptide-dependent mutants.
Journal of molecular microbiology and biotechnology 2000;2(3):321-30.
2000: Van Bambeke F; Kerkhofs A; Schanck A; Remacle C; Sonveaux E; Tulkens P M; Mingeot-Leclercq M P
Biophysical studies and intracellular destabilization of pH-sensitive liposomes.
Lipids 2000;35(2):213-23.
1999: Montenez J P; Van Bambeke F; Piret J; Brasseur R; Tulkens P M; Mingeot-Leclercq M P
Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models.
Toxicology and applied pharmacology 1999;156(2):129-40.
1999: Van Bambeke F; Chauvel M; Reynolds P E; Fraimow H S; Courvalin P
Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants.
Antimicrobial agents and chemotherapy 1999;43(1):41-7.
1998: Van Bambeke F; Gerbaux C; Michot J M; d'Yvoire M B; Montenez J P; Tulkens P M
Lysosomal alterations induced in cultured rat fibroblasts by long-term exposure to low concentrations of azithromycin.
The Journal of antimicrobial chemotherapy 1998;42(6):761-7.
1996: Montenez J P; Van Bambeke F; Piret J; Schanck A; Brasseur R; Tulkens P M; Mingeot-Leclercq M P
Interaction of the macrolide azithromycin with phospholipids. II. Biophysical and computer-aided conformational studies.
European journal of pharmacology 1996;314(1-2):215-27.
1996: Van Bambeke F; Montenez J P; Piret J; Tulkens P M; Courtoy P J; Mingeot-Leclercq M P
Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity.
European journal of pharmacology 1996;314(1-2):203-14.
1996: Gerbaux C; Van Bambeke F; Montenez J P; Piret J; Morlighem G; Tulkens P M
Hyperactivity of cathepsin B and other lysosomal enzymes in fibroblasts exposed to azithromycin, a dicationic macrolide antibiotic with exceptional tissue accumulation.
FEBS letters 1996;394(3):307-10.
1996: van Bambeke F; Mingeot-Leclercq M P; Brasseur R; Tulkens P M; Schanck A
Aminoglycoside antibiotics prevent the formation of non-bilayer structures in negatively-charged membranes. Comparative studies using fusogenic (bis(beta-diethylaminoethylether)hexestrol) and aggregating (spermine) agents.
Chemistry and physics of lipids 1996;79(2):123-35.
1995: Van Bambeke F; Tulkens P M; Brasseur R; Mingeot-Leclercq M P
Aminoglycoside antibiotics induce aggregation but not fusion of negatively-charged liposomes.
European journal of pharmacology 1995;289(2):321-33.
1993: Van Bambeke F; Mingeot-Leclercq M P; Schanck A; Brasseur R; Tulkens P M
Alterations in membrane permeability induced by aminoglycoside antibiotics: studies on liposomes and cultured cells.
European journal of pharmacology 1993;247(2):155-68.

Sign-in to see more